Otros idiomas GoodRx Holdings, Inc.

Acciones

GDRX

US38246G1085

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 26/04/2024			Varia. Cinco días.	Varia. 1 de enero.
7,19 ^USD	+1,55 %		+7,47 %	+7,31 %

10/04	GOODRX HOLDINGS, INC. : KeyBanc Capital Markets tiene una opinión positiva	ZM
25/03	Las acciones de GoodRx suben tras la mejora de Wells Fargo y el aumento del precio objetivo	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GDRX	26/04
GoodRx Holdings, Inc. (GDRX) Investors: June 21, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP	26/04
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GDRX	25/04
GDRX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that GoodRx Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit	25/04
GDRX Bronstein, Gewirtz & Grossman LLC Announces that GoodRx Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!	25/04
GoodRx Announces Date for 2024 Investor Day	24/04
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GoodRx	24/04
GDRX Alert: Rosen, Skilled Investor Counsel, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GDRX	23/04
GDRX Kessler Topaz Meltzer & Check, LLP Files A Securities Fraud Class Action Lawsuit Against GoodRX Holdings, Inc. And Encourages Investors With Losses To Contact The Firm	22/04
GoodRx Announces Date for First Quarter 2024 Earnings Release and Conference Call	11/04
North American Morning Briefing : Stock Futures -2-	11/04
North American Morning Briefing : Traders Await -2-	10/04
North American Morning Briefing : Markets Steady -2-	26/03
GoodRx Shares Jump Following Wells Fargo Upgrade, Price Target Boost	25/03
Top Premarket Gainers	25/03
GoodRx Interim CEO Extends Commitment to Company	14/03
North American Morning Briefing : Stock Futures -2-	04/03
GoodRx Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/02
GoodRx Q4 Adjusted Earnings, Revenue Gain; Sets Q1, 2024 Revenue Outlook; Approves $450 Million Share Buyback Plan	29/02
Earnings Flash (GDRX) GOODRX HOLDINGS Reports Q4 Revenue $196.6M, vs. Street Est of $195.9M	29/02

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas GoodRx Holdings, Inc.

Acciones

GDRX

US38246G1085

Otros idiomas

Filtros